Références Bibliographiques :

AbdAlla, S., Lother, H., Abdel-tawab, A.M. and Quitterer, U. (2001a) The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem, 276, 39721-39726.

AbdAlla, S., Lother, H., el Massiery, A. and Quitterer, U. (2001b) Increased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness. Nat Med, 7, 1003-1009.

AbdAlla, S., Lother, H. and Quitterer, U. (2000) AT1-receptor heterodimers show enhanced G-protein activation and altered receptor sequestration. Nature, 407, 94-98.

AbdAlla, S., Zaki, E., Lother, H. and Quitterer, U. (1999) Involvement of the amino terminus of the B(2) receptor in agonist- induced receptor dimerization. J Biol Chem, 274, 26079-26084.

Amar, S., Kitabgi, P. and Vincent, J.P. (1986) Activation of phosphatidylinositol turnover by neurotensin receptors in the human colonic adenocarcinoma cell line HT29. FEBS Lett, 201, 31-36.

Angers, S., Salahpour, A. and Bouvier, M. (2002) DIMERIZATION: An Emerging Concept for G Protein-Coupled Receptor Ontogeny and Function. Annu Rev Pharmacol Toxicol, 42, 409-435.

Angers, S., Salahpour, A., Joly, E., Hilairet, S., Chelsky, D., Dennis, M. and Bouvier, M. (2000) Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). Proc Natl Acad Sci U S A, 97, 3684-3689.

Asselin, M.L., Dubuc, I., Coquerel, A. and Costentin, J. (2001) Localization of neurotensin NTSR2 receptors in rat brain, using. Neuroreport, 12, 1087-1091.

Bai, M., Trivedi, S. and Brown, E.M. (1998) Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J Biol Chem, 273, 23605-23610.

Bai, M., Trivedi, S., Kifor, O., Quinn, S.J. and Brown, E.M. (1999) Intermolecular interactions between dimeric calcium-sensing receptor monomers are important for its normal function. Proc Natl Acad Sci U S A, 96, 2834-2839.

Baldwin, J.M. (1993) The probable arrangement of the helices in G protein-coupled receptors. Embo J, 12, 1693-1703.

Baldwin, J.M. (1994) Structure and function of receptors coupled to G proteins. Curr Opin Cell Biol, 6, 180-190.

Barroso, S., Richard, F., Nicolas-Etheve, D., Reversat, J.L., Bernassau, J.M., Kitabgi, P. and Labbé-Jullié, C. (2000) Identification of residues involved in neurotensin binding and modeling of the agonist binding site in neurotensin receptor 1. J Biol Chem, 275, 328-336.

Betancur, C., Canton, M., Burgos, A., Labeeuw, B., Gully, D., Rostene, W. and Pelaprat, D. (1998) Characterization of binding sites of a new neurotensin receptor antagonist, [3H]SR 142948A, in the rat brain. Eur J Pharmacol, 343, 67-77.

Bockaert, J. and Pin, J.P. (1998) [Use of a G-protein-coupled receptor to communicate. An evolutionary success]. C R Acad Sci III, 321, 529-551.

Bockaert, J. and Pin, J.P. (1999) Molecular tinkering of G protein-coupled receptors: an evolutionary success. Embo J, 18, 1723-1729.

Bohm, S.K., Grady, E.F. and Bunnett, N.W. (1997) Regulatory mechanisms that modulate signalling by G-protein-coupled receptors. Biochem J, 322, 1-18.

Botto, J.M., Chabry, J., Sarret, P., Vincent, J.P. and Mazella, J. (1998) Stable expression of the mouse levocabastine-sensitive neurotensin receptor in HEK 293 cell line: binding properties, photoaffinity labeling, and internalization mechanism. Biochem Biophys Res Commun, 243, 585-590.

Botto, J.M., Sarret, P., Vincent, J.P. and Mazella, J. (1997) Identification and expression of a variant isoform of the levocabastine-sensitive neurotensin receptor in the mouse central nervous system. FEBS Lett, 400, 211-214.

Botto, J.M. (1997) La famille des récepteurs membranaires couplés aux protéines-G. Un modèle d'étude : les récepteurs des neuropeptides neurotensine et neuromédine N. Thèse, Nice-Sophia Antipolis.

Boudin, H., Pelaprat, D., Rostene, W. and Beaudet, A. (1996) Cellular distribution of neurotensin receptors in rat brain: immunohistochemical study using an antipeptide antibody against the cloned high affinity receptor. J Comp Neurol, 373, 76-89.

Bouvier, M. (2001) Oligomerization of G-protein-coupled transmitter receptors. Nat Rev Neurosci, 2, 274-286.

Bozou, J.C., Amar, S., Vincent, J.P. and Kitabgi, P. (1986) Neurotensin-mediated inhibition of cyclic AMP formation in neuroblastoma N1E115 cells: involvement of the inhibitory GTP-binding component of adenylate cyclase. Mol Pharmacol, 29, 489-496.

Cao, T.T., Deacon, H.W., Reczek, D., Bretscher, A. and von Zastrow, M. (1999) A kinase-regulated PDZ-domain interaction controls endocytic sorting of the beta2-adrenergic receptor. Nature, 401, 286-290.

Chabry, J., Botto, J.M., Nouel, D., Beaudet, A., Vincent, J.P. and Mazella, J. (1995) Thr-422 and Tyr-424 residues in the carboxyl terminus are critical for the internalization of the rat neurotensin receptor. J Biol Chem, 270, 2439-2442.

Chabry, J., Gaudriault, G., Vincent, J.P. and Mazella, J. (1993) Implication of various forms of neurotensin receptors in the mechanism of internalization of neurotensin in cerebral neurons. J Biol Chem, 268, 17138-17144.

Chalon, P., Vita, N., Kaghad, M., Guillemot, M., Bonnin, J., Delpech, B., Le Fur, G., Ferrara, P. and Caput, D. (1996) Molecular cloning of a levocabastine-sensitive neurotensin binding site. FEBS Lett, 386, 91-94.

Checler, F., Mazella, J., Kitabgi, P. and Vincent, J.P. (1986) High-affinity receptor sites and rapid proteolytic inactivation of neurotensin in primary cultured neurons. J Neurochem, 47, 1742-1748.

Ciruela, F., Casado, V., Mallol, J., Canela, E.I., Lluis, C. and Franco, R. (1995) Immunological identification of A1 adenosine receptors in brain cortex. J Neurosci Res, 42, 818-828.

Clapham, D.E. and Neer, E.J. (1993) New roles for G-protein beta gamma-dimers in transmembrane signalling. Nature, 365, 403-406.

Clapham, D.E. and Neer, E.J. (1997) G protein beta gamma subunits. Annu Rev Pharmacol Toxicol, 37, 167-203.

Cvejic, S. and Devi, L.A. (1997) Dimerization of the delta opioid receptor: implication for a role in receptor internalization. J Biol Chem, 272, 26959-26964.

Devi, L.A. (2001) Heterodimerization of G-protein-coupled receptors: pharmacology, signaling and trafficking. Trends Pharmacol Sci, 22, 532-537.

Diviani, D., Lattion, A.L., Larbi, N., Kunapuli, P., Pronin, A., Benovic, J.L. and Cotecchia, S. (1996) Effect of different G protein-coupled receptor kinases on phosphorylation and desensitization of the alpha1B-adrenergic receptor. J Biol Chem, 271, 5049-5058.

Dubuc, I., Costentin, J., Terranova, J.P., Barnouin, M.C., Soubrie, P., Le Fur, G., Rostene, W. and Kitabgi, P. (1994) The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes. Br J Pharmacol, 112, 352-354.

Dubuc, I., Sarret, P., Labbé-Jullié, C., Botto, J.M., Honoré, E., Bourdel, E., Martinez, J., Costentin, J., Vincent, J.P., Kitabgi, P. and Mazella, J. (1999) Identification of the receptor subtype involved in the analgesic effect of neurotensin. J Neurosci, 19, 503-510.

Dulac, C. and Axel, R. (1998) Expression of candidate pheromone receptor genes in vomeronasal neurons. Chem Senses, 23, 467-475.

Faure, M.P., Alonso, A., Nouel, D., Gaudriault, G., Dennis, M., Vincent, J.P. and Beaudet, A. (1995) Somatodendritic internalization and perinuclear targeting of neurotensin in the mammalian brain. J Neurosci, 15, 4140-4147.

Ferguson, S.S. (2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev, 53, 1-24.

Fernandez, L.M. and Puett, D. (1996) Lys583 in the third extracellular loop of the lutropin/choriogonadotropin receptor is critical for signaling. J Biol Chem, 271, 925-930.

Fukushima, Y., Asano, T., Saitoh, T., Anai, M., Funaki, M., Ogihara, T., Katagiri, H., Matsuhashi, N., Yazaki, Y. and Sugano, K. (1997) Oligomer formation of histamine H2 receptors expressed in Sf9 and COS7 cells. FEBS Lett, 409, 283-286.

Gage, R.M., Kim, K.A., Cao, T.T. and von Zastrow, M. (2001) A transplantable sorting signal that is sufficient to mediate rapid recycling of G protein-coupled receptors. J Biol Chem, 276, 44712-44720.

George, S.R., Lee, S.P., Varghese, G., Zeman, P.R., Seeman, P., Ng, G.Y. and O'Dowd, B.F. (1998) A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization. J Biol Chem, 273, 30244-30248.

Gines, S., Hillion, J., Torvinen, M., Le Crom, S., Casado, V., Canela, E.I., Rondin, S., Lew, J.Y., Watson, S., Zoli, M., Agnati, L.F., Verniera, P., Lluis, C., Ferre, S., Fuxe, K. and Franco, R. (2000) Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes. Proc Natl Acad Sci U S A, 97, 8606-8611.

Grady, E., Bohm, S., McConalogue, K., Garland, A., Ansel, J., Olerud, J. and Bunnett, N. (1997) Mechanisms attenuating cellular responses to neuropeptides: extracellular degradation of ligands and desensitization of receptors. J Investig Dermatol Symp Proc, 2, 69-75.

Gruenberg, J. (2001) The endocytic pathway: a mosaic of domains. Nat Rev Mol Cell Biol, 2, 721-730.

Gully, D., Canton, M., Boigegrain, R., Jeanjean, F., Molimard, J.C., Poncelet, M., Gueudet, C., Heaulme, M., Leyris, R., Brouard, A. and et al. (1993) Biochemical and pharmacological profile of a potent and selective nonpeptide antagonist of the neurotensin receptor. Proc Natl Acad Sci U S A, 90, 65-69.

Gully, D., Labeeuw, B., Boigegrain, R., Oury-Donat, F., Bachy, A., Poncelet, M., Steinberg, R., Suaud-Chagny, M.F., Santucci, V., Vita, N., Pecceu, F., Labbé-Jullié, C., Kitabgi, P., Soubrié, P., Le Fur, G. and Maffrand, J.P. (1997) Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist. J. Pharmacol. Exp. Ther., 280, 802-812.

Haga, K., Kameyama, K., Haga, T., Kikkawa, U., Shiozaki, K. and Uchiyama, H. (1996) Phosphorylation of human m1 muscarinic acetylcholine receptors by G protein-coupled receptor kinase 2 and protein kinase C. J Biol Chem, 271, 2776-2782.

Hebert, T.E., Moffett, S., Morello, J.P., Loisel, T.P., Bichet, D.G., Barret, C. and Bouvier, M. (1996) A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem, 271, 16384-16392.

Hermans, E. and Challiss, R.A. (2001) Structural, signalling and regulatory properties of the group I metabotropic glutamate receptors: prototypic family C G-protein-coupled receptors. Biochem J, 359, 465-484.

Herrada, G. and Dulac, C. (1997) A novel family of putative pheromone receptors in mammals with a topographically organized and sexually dimorphic distribution. Cell, 90, 763-773.

Heuss, C. and Gerber, U. (2000) G-protein-independent signaling by G-protein-coupled receptors. Trends Neurosci, 23, 469-475.

Innamorati, G., Sadeghi, H.M., Tran, N.T. and Birnbaumer, M. (1998) A serine cluster prevents recycling of the V2 vasopressin receptor. Proc Natl Acad Sci U S A, 95, 2222-2226.

Ji, T.H., Grossmann, M. and Ji, I. (1998) G protein-coupled receptors. I. Diversity of receptor-ligand interactions. J Biol Chem, 273, 17299-17302.

Jones, K.A., Borowsky, B., Tamm, J.A., Craig, D.A., Durkin, M.M., Dai, M., Yao, W.J., Johnson, M., Gunwaldsen, C., Huang, L.Y., Tang, C., Shen, Q., Salon, J.A., Morse, K., Laz, T., Smith, K.E., Nagarathnam, D., Noble, S.A., Branchek, T.A. and Gerald, C. (1998) GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature, 396, 674-679.

Jordan, B.A. and Devi, L.A. (1999) G-protein-coupled receptor heterodimerization modulates receptor function. Nature, 399, 697-700.

Jordan, B.A., Trapaidze, N., Gomes, I., Nivarthi, R. and Devi, L.A. (2001) Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation. Proc Natl Acad Sci U S A, 98, 343-348.

Kaupmann, K., Huggel, K., Heid, J., Flor, P.J., Bischoff, S., Mickel, S.J., McMaster, G., Angst, C., Bittiger, H., Froestl, W. and Bettler, B. (1997) Expression cloning of GABA(B) receptors uncovers similarity to metabotropic glutamate receptors. Nature, 386, 239-246.

Kaupmann, K., Malitschek, B., Schuler, V., Heid, J., Froestl, W., Beck, P., Mosbacher, J., Bischoff, S., Kulik, A., Shigemoto, R., Karschin, A. and Bettler, B. (1998) GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature, 396, 683-687.

Kishi, M., Liu, X., Hirakawa, T., Reczek, D., Bretscher, A. and Ascoli, M. (2001) Identification of two distinct structural motifs that, when added to the C-terminal tail of the rat LH receptor, redirect the internalized hormone-receptor complex from a degradation to a recycling pathway. Mol Endocrinol, 15, 1624-1635.

Kitabgi, P., Carraway, R., Van Rietschoten, J., Granier, C., Morgat, J.L., Menez, A., Leeman, S. and Freychet, P. (1977) Neurotensin: specific binding to synaptic membranes from rat brain. Proc Natl Acad Sci U S A, 74, 1846-1850.

Kitabgi, P., Kwan, C.Y., Fox, J.E. and Vincent, J.P. (1984) Characterization of neurotensin binding to rat gastric smooth muscle receptor sites. Peptides, 5, 917-923.

Kitabgi, P., Rostene, W., Dussaillant, M., Schotte, A., Laduron, P.M. and Vincent, J.P. (1987) Two populations of neurotensin binding sites in murine brain: discrimination by the antihistamine levocabastine reveals markedly different radioautographic distribution. Eur J Pharmacol, 140, 285-293.

Kong, H., Raynor, K., Yasuda, K., Bell, G.I. and Reisine, T. (1993) Mutation of an aspartate at residue 89 in somatostatin receptor subtype 2 prevents Na+ regulation of agonist binding but does not alter receptor-G protein association. Mol Pharmacol, 44, 380-384.

Krupnick, J.G. and Benovic, J.L. (1998) The role of receptor kinases and arrestins in G protein-coupled receptor regulation. Annu Rev Pharmacol Toxicol, 38, 289-319.

Labbé-Jullié, C., Barroso, S., Nicolas-Eteve, D., Reversat, J.L., Botto, J.M., Mazella, J., Bernassau, J.M. and Kitabgi, P. (1998) Mutagenesis and modeling of the neurotensin receptor NTR1. Identification of residues that are critical for binding SR 48692, a nonpeptide neurotensin antagonist. J Biol Chem, 273, 16351-16357.

Laurent, P., Clerc, P., Mattei, M.G., Forgez, P., Dumont, X., Ferrara, P., Caput, D. and Rostene, W. (1994) Chromosomal localization of mouse and human neurotensin receptor genes. Mamm Genome, 5, 303-306.

Lepee-Lorgeoux, I., Betancur, C., Rostene, W. and Pelaprat, D. (1999) Differential ontogenetic patterns of levocabastine-sensitive neurotensin NT2 receptors and of NT1 receptors in the rat brain revealed by in situ hybridization. Brain Res Dev Brain Res, 113, 115-131.

Leurs, R., Smit, M.J., Alewijnse, A.E. and Timmermann, H. (1998) Agonist-independent regulation of constitutively active G-protein-coupled receptors. TIBS, 23, 418-422.

Ling, K., Wang, P., Zhao, J., Wu, Y.L., Cheng, Z.J., Wu G.X., Hu, W., Ma, L. and Pei, G. (1999) Five-transmembrane domains appear sufficient for a G protein-coupled receptor : functional five-transmembrane domain chemokine receptors. . Proc Natl Acad Sci U S A, 14, 7922-7927.

Lohse, M.J., Benovic, J.L., Caron, M.G. and Lefkowitz, R.J. (1990) Multiple pathways of rapid beta 2-adrenergic receptor desensitization. Delineation with specific inhibitors. J Biol Chem, 265, 3202-3211.

Luttrell, L.M., Daaka, Y. and Lefkowitz, R.J. (1999) Regulation of tyrosine kinase cascades by G-protein-coupled receptors Curr Opin Cell Biol, 11, 177-183.

Maggio, R., Barbier, P., Fornai, F. and Corsini, G.U. (1996) Functional role of the third cytoplasmic loop in muscarinic receptor dimerization. J Biol Chem, 271, 31055-31060.

Marsault, R. and Frelin, C. (1992) Activation by nitric oxide of guanylate cyclase in endothelial cells from brain capillaries. J Neurochem, 59, 942-945.

Martin, S., Vincent, J.P. and Mazella, J. (2002) Recycling ability of the mouse et the human neurotensin type 2 receptors depends on a single tyrosine residue. J Cell Sci, 115, 165-173.

Mazella, J., Amar, S., Bozou, J.C., Kitabgi, P. and Vincent, J.P. (1987) Functional properties and molecular structure of central and peripheral neurotensin receptors. J Recept Res, 7, 157-165.

Mazella, J., Botto, J.M., Guillemare, E., Coppola, T., Sarret, P. and Vincent, J.P. (1996) Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain. J Neurosci, 16, 5613-5620.

Mazella, J., Chabry, J., Kitabgi, P. and Vincent, J.P. (1988) Solubilization and characterization of active neurotensin receptors from mouse brain. J Biol Chem, 263, 144-149.

Mazella, J., Leonard, K., Chabry, J., Kitabgi, P., Vincent, J.P. and Beaudet, A. (1991) Binding and internalization of iodinated neurotensin in neuronal cultures from embryonic mouse brain. Brain Res, 564, 249-255.

Mazella, J., Poustis, C., Labbé, C., Checler, F., Kitabgi, P., Granier, C., van Rietschoten, J. and Vincent, J.P. (1983) Monoiodo-[Trp11]neurotensin, a highly radioactive ligand of neurotensin receptors. Preparation, biological activity, and binding properties to rat brain synaptic membranes. J Biol Chem, 258, 3476-3481.

Mendez, M., Souaze, F., Nagano, M., Kelly, P.A., Rostene, W. and Forgez, P. (1997) High affinity neurotensin receptor mRNA distribution in rat brain and peripheral tissues. Analysis by quantitative RT-PCR. J Mol Neurosci, 9, 93-102.

Monnot, C., Bihoreau, C., Conchon, S., Curnow, K.M., Corvol, P. and Clauser, E. (1996) Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants. J Biol Chem, 271, 1507-1513.

Neer, E.J. (1995) Heterotrimeric G proteins: organizers of transmembrane signals. Cell, 80, 249-257.

Ng, G.Y., O'Dowd, B.F., Lee, S.P., Chung, H.T., Brann, M.R., Seeman, P. and George, S.R. (1996) Dopamine D2 receptor dimers and receptor-blocking peptides. Biochem Biophys Res Commun, 227, 200-204.

Nimchinsky, E.A., Hof, P.R., Janssen, W.G., Morrison, J.H. and Schmauss, C. (1997) Expression of dopamine D3 receptor dimers and tetramers in brain and in transfected cells. J Biol Chem, 272, 29229-29237.

Nouel, D., Faure, M.P., St Pierre, J.A., Alonso, R., Quirion, R. and Beaudet, A. (1997) Differential binding profile and internalization process of neurotensin via neuronal and glial receptors. J Neurosci, 17, 1795-1803.

Nouel, D., Sarret, P., Vincent, J.P., Mazella, J. and Beaudet, A. (1999) Pharmacological, molecular and functional characterization of glial neurotensin receptors. Neuroscience, 94, 1189-1197.

Oakley, R.H., Laporte, S.A., Holt, J.A., Barak L.S. and Caron, M.G. (2001) Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-b-arrestin complexes after receptor endocytosis. J Biol Chem, 276, 19452-19460.

Okamoto, T., Sekiyama, N., Otsu, M., Shimada, Y., Sato, A., Nakanishi, S. and Jingami, H. (1998) Expression and purification of the extracellular ligand binding region of metabotropic glutamate receptor subtype 1. J Biol Chem, 273, 13089-13096.

Pantaloni, C., Brabet, P., Bilanges, B., Dumuis, A., Houssami, S., Spengler, D., Bockaert, J. and Journot, L. (1996) Alternative splicing in the N-terminal extracellular domain of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor modulates receptor selectivity and relative potencies of PACAP-27 and PACAP-38 in phospholipase C activation. J Biol Chem, 271, 22146-22151.

Parent, J.L., Le Gouill, C., Rola-Pleszczynski, M. and Stankova, J. (1996) Mutation of an aspartate at position 63 in the human platelet- activating factor receptor augments binding affinity but abolishes G- protein-coupling and inositol phosphate production. Biochem Biophys Res Commun, 219, 968-975.

Perry, S.J. and Lefkowitz, R.J. (2002) Arresting developments in heptahelical receptor signaling and regulation. Trends Cell Biol, 12, 130-138.

Pettibone, D.J., Hess, J.F., Hey, P.J., Jacobson, M.A., Leviten, M., Lis, E.V., Mallorga, P.J., Pascarella, D.M., Snyder, M.A., Williams, J.B. and Zeng, Z. (2002) The effects of deleting the mouse neurotensin receptor NTR1 on central and peripheral responses to neurotensin. J Pharmacol Exp Ther, 300, 305-313.

Pettibone, D.J. and Totaro, J.A. (1987) High affinity binding of [3H]neurotensin of rat uterus. Peptides, 8, 1169-1172.

Pfeiffer, M., Koch, T., Schroder, H., Klutzny, M., Kirscht, S., Kreienkamp, H.J., Hollt, V. and Schulz, S. (2001) Homo- and heterodimerization of somatostatin receptor subtypes. Inactivation of sst(3) receptor function by heterodimerization with sst(2A). J Biol Chem, 276, 14027-14036.

Pfeiffer, M., Koch, T., Schroder, H., Laugsch, M., Hollt, V. and Schulz, S. (2002) Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization and desensitization. J Biol Chem, 14, 14.

Pippig, S., Andexinger, S., Daniel, K., Puzicha, M., Caron, M.G., Lefkowitz, R.J. and Lohse, M.J. (1993) Overexpression of beta-arrestin and beta-adrenergic receptor kinase augment desensitization of beta 2-adrenergic receptors. J Biol Chem, 268, 3201-3208.

Poinot-Chazel, C., Portier, M., Bouaboula, M., Vita, N., Pecceu, F., Gully, D., Monroe, J.G., Maffrand, J.P., Le Fur, G. and Casellas, P. (1996) Activation of mitogen-activated protein kinase couples neurotensin receptor stimulation to induction of the primary response gene Krox-24. Biochem J, 320, 145-151.

Probst, W.C., Snyder, L.A., Schuster, D.I., Brosius, J. and Sealfon, S.C. (1992) Sequence alignment of the G-protein coupled receptor superfamily. DNA Cell Biol, 11, 1-20.

Richard, F., Barroso, S., Martinez, J., Labbé-Jullié, C. and Kitabgi, P. (2001) Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2. Mol Pharmacol, 60, 1392-1398.

Richard, F. (2001) Mutagenèse, modélisation et pharmacologie des récepteurs de la neurotensine couplés aux protéines-G, NTSR1 et NTSR2. Thèse, Nice-Sophia Antipolis.

Rocheville, M., Lange, D.C., Kumar, U., Patel, S.C., Patel, R.C. and Patel, Y.C. (2000a) Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science, 288, 154-157.

Rocheville, M., Lange, D.C., Kumar, U., Sasi, R., Patel, R.C. and Patel, Y.C. (2000b) Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J Biol Chem, 275, 7862-7869.

Rodriguez-Frade, J.M., Vila-Coro, A.J., de Ana, A.M., Albar, J.P., Martinez, A.C. and Mellado, M. (1999) The chemokine monocyte chemoattractant protein-1 induces functional responses through dimerization of its receptor CCR2. Proc Natl Acad Sci U S A, 96, 3628-3633.

Romano, C., Yang, W.L. and O'Malley, K.L. (1996) Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J Biol Chem, 271, 28612-28616.

Sadoul, J.L., Mazella, J., Amar, S., Kitabgi, P. and Vincent, J.P. (1984) Preparation of neurotensin selectively iodinated on the tyrosine 3 residue. Biological activity and binding properties on mammalian neurotensin receptors. Biochem Biophys Res Commun, 120, 812-819.

Sarret, P., Beaudet, A., Vincent, J.P. and Mazella, J. (1998) Regional and cellular distribution of low affinity neurotensin receptor mRNA in adult and developing mouse brain. J Comp Neurol, 394, 344-356.

Sarret, P., Nouel, D., Dal Farra, C., Vincent, J.P., Beaudet, A. and Mazella, J. (1999) Receptor-mediated internalization is critical for the inhibition of the expression of growth hormone by somatostatin in the pituitary cell line AtT-20. J Biol Chem, 274, 19294-19300.

Sarret, P. (2000) Signalisation par les récepteurs membranaires couplés aux protéines-G. Etude fonctionnelle des récepteurs de la somatostatine et de la neurotensine. Thèse, Nice-Sophia Antipolis.

Sarret, P., Gendron, L., Kilian, P., Nguyen, H.M.K., Gallo-Payet, N., Payet M.D. and Beaudet, A. (2002) Pharmacology and functional properties of NTS2 neurotensin receptors in cerebellar granule cells. J Biol Chem, in press.

Schlador, M.L. and Nathanson, N.M. (1997) Synergistic regulation of m2 muscarinic acetylcholine receptor desensitization and sequestration by G protein-coupled receptor kinase- 2 and beta-arrestin-1. J Biol Chem, 272, 18882-18890.

Schotte, A. and Laduron, P.M. (1987) Different postnatal ontogeny of two [3H]neurotensin binding sites in rat brain. Brain Res, 408, 326-328.

Schotte, A., Leysen, J.E. and Laduron, P.M. (1986) Evidence for a displaceable non-specific [3H]neurotensin binding site in rat brain. Naunyn Schmiedebergs Arch Pharmacol, 333, 400-405.

Scott, M.G., Benmerah, A., Muntaner, O. and Marullo, S. (2002) Recruitment of activated G-protein-coupled receptors to pre-existing clathrin-coated pits in living cells. J Biol Chem, 277, 3552-3557.

Strader, C.D., Fong, T.M., Graziano, M.P. and Tota, M.R. (1995) The family of G-protein-coupled receptors. FASEB J., 9, 745-754.

Sun, Y.J., Maeno, H., Aoki, S. and Wada, K. (2001) Mouse neurotensin receptor 2 gene (Ntsr2): genomic organization, transcriptional regulation and genetic mapping on chromosome 12. Brain Res Mol Brain Res, 95, 167-171.

Takei, K. and Haucke, V. (2001) Clathrin-mediated endocytosis: membrane factors pull the trigger. Trends Cell Biol, 11, 385-391.

Tanaka, K., Masu, M. and Nakanishi, S. (1990) Structure and functional expression of the cloned rat neurotensin receptor. Neuron, 4, 847-854.

Trejo, J. and Coughlin, S.R. (1999) The cytoplasmic tails of protease-activated receptor-1 and substance P receptor specify sorting to lysosomes versus recycling. J Biol Chem, 274, 2216-2224.

Trejo, J., Hammes, S.R. and Coughlin, S.R. (1998) Termination of signaling by protease-activated receptor-1 is linked to lysosomal sorting. Proc Natl Acad Sci U S A, 95, 13698-13702.

Trumpp-Kallmeyer, S., Chini, B., Mouillac, B., Barberis, C., Hoflack, J. and Hibert, M. (1995) Towards understanding the role of the first extracellular loop for the binding of peptide hormones to G-protein coupled receptors. Pharm Acta Helv, 70, 255-262.

Tsao, P. and von Zastrow, M. (2000) Down regulation of G protein-coupled receptors. Current Opinion in Neurobiology, 10, 365-369.

Uhl, G.R., Bennett, J.P., Jr. and Snyder, S.H. (1977) Neurotensin, a central nervous system peptide: apparent receptor binding in brain membranes. Brain Res, 130, 299-313.

Ulrich, C.D., 2nd, Holtmann, M. and Miller, L.J. (1998) Secretin and vasoactive intestinal peptide receptors: members of a unique family of G protein-coupled receptors. Gastroenterology, 114, 382-397.

Vandenbulcke, F., Nouel, D., Vincent, J., Mazella, J. and Beaudet, A. (2000) Ligand-induced internalization of neurotensin in transfected COS-7 cells: differential intracellular trafficking of ligand and receptor. J Cell Sci, 113, 2963-2975.

Vila-Coro, A.J., Mellado, M., Martin de Ana, A., Lucas, P., del Real, G., Martinez, A.C. and Rodriguez-Frade, J.M. (2000) HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization. Proc Natl Acad Sci U S A, 97, 3388-3393.

Vincent, J.P., Mazella, J. and Kitabgi, P. (1999) Neurotensin and neurotensin receptors. Trends Pharmacol Sci, 20, 302-309.

Vita, N., Laurent, P., Lefort, S., Chalon, P., Dumont, X., Kaghad, M., Gully, D., Le Fur, G., Ferrara, P. and Caput, D. (1993) Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor. FEBS Lett, 317, 139-142.

Vita, N., Oury-Donat, F., Chalon, P., Guillemot, M., Kaghad, M., Bachy, A., Thurneyssen, O., Garcia, S., Poinot-Chazel, C., Casellas, P., Keane, P., Le Fur, G., Maffrand, J.P., Soubrie, P., Caput, D. and Ferrara, P. (1998) Neurotensin is an antagonist of the human neurotensin NT2 receptor expressed in Chinese hamster ovary cells. Eur J Pharmacol, 360, 265-272.

Von Zastrow, M. and Kobilka, B.K. (1992) Ligand-regulated internalization and recycling of human beta 2- adrenergic receptors between the plasma membrane and endosomes containing transferrin receptors. J Biol Chem, 267, 3530-3538.

White, J.H., Wise, A., Main, M.J., Green, A., Fraser, N.J., Disney, G.H., Barnes, A.A., Emson, P., Foord, S.M. and Marshall, F.H. (1998) Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature, 396, 679-682.

Xie, Z., Lee, S.P., O'Dowd, B.F. and George, S.R. (1999) Serotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone and heterodimers when co-expressed. FEBS Lett, 456, 63-67.

Yamada, M., Lombet, A., Forgez, P. and Rostene, W. (1998) Distinct functional characteristics of levocabastine sensitive rat neurotensin NT2 receptor expressed in Chinese hamster ovary cells. Life Sci, 62, 375-380.

Yamada, M., Watson, M.A. and Richelson, E. (1994) Deletion mutation in the putative third intracellular loop of the rat neurotensin receptor abolishes polyphosphoinositide hydrolysis but not cyclic AMP formation in CHO-K1 cells. Mol Pharmacol, 46, 470-476.

Zeng, F.Y. and Wess, J. (1999) Identification and molecular characterization of m3 muscarinic receptor dimers. J Biol Chem, 274, 19487-19497.

Zhang, M., Turnbaugh, D., Cofie, D., Dogan, S., Koshida, H., Fugate, R. and Kem, D.C. (1996) Protein kinase C modulation of cardiomyocyte angiotensin II and vasopressin receptor desensitization. Hypertension, 27, 269-275.

Zhu, X. and Wess, J. (1998) Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. Biochemistry, 37, 15773-15784.

Zsürger, N., Chabry, J., Coquerel, A. and Vincent, J.P. (1992) Ontogenesis and binding properties of high-affinity neurotensin receptors in human brain. Brain Res, 586, 303-310.